{"organizations": [], "uuid": "2eee7dfbf476246a40486d65a7b40d0bfae951e7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.menafn.com", "main_image": "http://menafn.com/images/shared/menafnlogo_sm.gif", "site_section": "http://www.menafn.com/rss/menafn_Business_Finance.xml", "section_title": "MENAFN.com Business/Finance", "url": "http://www.menafn.com/1094293689/Teva-Pharmaceutical-acquires-Allergan-for-USD405b?src=RSS", "country": "US", "title": "Teva Pharmaceutical acquires Allergan for USD40.5b", "performance_score": 0, "site": "menafn.com", "participants_count": 1, "title_full": "Teva Pharmaceutical acquires Allergan for USD40.5b | MENAFN.COM", "spam_score": 0.0, "site_type": "news", "published": "2015-07-28T03:00:00.000+03:00", "replies_count": 0, "uuid": "2eee7dfbf476246a40486d65a7b40d0bfae951e7"}, "author": "", "url": "http://www.menafn.com/1094293689/Teva-Pharmaceutical-acquires-Allergan-for-USD405b?src=RSS", "ord_in_thread": 0, "title": "Teva Pharmaceutical acquires Allergan for USD40.5b", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "(MENAFN) Teva Pharmaceutical Industries approved the acquisition of Allergan Plc's genetic drugs business for USD40.5 billion in a cash-and-stock deal, The Peninsula Qatar reported.\n\nThe deal, that will turn the firm into one of the world's largest pharmaceutical firm, prompted Teva to drop its USD40 billionn hostile bid for Mylan, which used a poison pill-style defence to fight the takeover.\n\nThe acquisition also allows the Dublin-based Allergan, which combined generics maker Actavic earlier this year in a USD66 billion deal, to focus on branded drugs and pay down its debt. \n\n\"Allergan's business is more high-end (than Mylan). It's a more interesting business ... a profitable business and it's well managed,\" an analyst at brokerage Excellence Nessuah said.", "external_links": [], "published": "2015-07-28T03:00:00.000+03:00", "crawled": "2015-07-28T19:34:10.423+03:00", "highlightTitle": ""}